Active — Not RecruitingNot Applicable

Sense of Coherence and Quality of Life in Prostate Cancer Patients Treated With Radical Radiotherapy

Slovenia250 participantsStarted 2021-09-01

Plain-language summary

This prospective single-group interventional study evaluates the relationship between sense of coherence (SOC), health-related quality of life (HRQL), and self-rated health (SRH) in patients with prostate cancer treated with radical radiotherapy. The study aims to identify factors that may contribute to improved quality of life and coping after treatment. Participants complete validated questionnaires assessing HRQL (EORTC QLQ-C30), SOC (SOC-13), and self-rated health at predefined time points. In addition, objectively assessed treatment-related problems are evaluated using a structured physician-led interview. Data are collected before the start of radiotherapy, at the end of radiotherapy, and one year after completion of treatment.

Who can participate

Age range18 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male patients aged 18 years and older * Histologically confirmed prostate cancer * Planned for radical radiotherapy treatment * Ability to understand and complete questionnaires independently * Written informed consent provided Exclusion Criteria: * Previous radiotherapy for prostate cancer * Metastatic disease at the time of enrollment * Any condition that, in the investigator's opinion, would interfere with study participation or data quality

What they're measuring

Health-Related Quality of Life (HRQL)

Timeframe: Baseline (before radiotherapy), end of radiotherapy, and 1 year after completion of radiotherapy

Trial details

NCT IDNCT07431684

SponsorInstitute of Oncology Ljubljana

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-09-01

View on ClinicalTrials.gov More Prostate Cancer trials